Actively Recruiting

Phase Not Applicable
Age: 3Years +
All Genders
NCT06845501

Purine Supplementation in Patients With AICA-Ribosiduria

Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2026-05-08

10

Participants Needed

1

Research Sites

209 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire de Saint Etienne

Lead Sponsor

U

University Hospital of Saint-Etienne

Collaborating Sponsor

AI-Summary

What this Trial Is About

AICA-Ribosiduria due to ATIC deficiency is a rare genetic metabolic disease that affects less than 10 patients (PMID: 32557644). It results in severe polyhandicap linked to neurodevelopmental disorders, visual impairment, growth retardation, severe spinal deformities and scoliosis, and often early-onset epilepsy. The disease is caused by dysfunction of the ATIC enzyme, which is involved in de novo purine biosynthesis. A recent study (PMID: 38244287) reported a decrease in disease biomarkers in a single patient after 3 months on a purine-rich diet, which persisted for at least 1 year. The investigators propose to replicate this study on several patients to investigate the potential of this treatment for this severe orphan disease.

CONDITIONS

Official Title

Purine Supplementation in Patients With AICA-Ribosiduria

Who Can Participate

Age: 3Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individual affected by AICA-ribosiduria due to ATIC deficiency
Not Eligible

You will not qualify if you...

  • Individual already on a purine-rich diet
  • Theoretical contraindication to a purine-rich diet

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chu Saint-Etienne

Saint-Etienne, France, 42055

Actively Recruiting

Loading map...

Research Team

F

Francis RAMOND, doctor of medicine

CONTACT

B

Béatrice DEYGAS, Project manager

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here